On the issue of obtaining platelet-rich plasma
https://doi.org/10.35401/2500-0268-2022-25-1-38-43
Abstract
Objective: To determine the optimal technological modes for the preparation of platelet-rich plasma (PRP) using standard laboratory equipment.
Material and methods: Blood for the research was taken from 25 healthy volunteers. Its centrifugation was performed on a standard CM-6M laboratory centrifuge using various modes and two types of vacuum tubes with lithium heparin containing separation gel and without it. The number of platelets and leukocytes was calculated in the upper, lower and middle layers of the obtained plasma sample.
Results: Plasma samples obtained during centrifugation modes from 415 to 1660 g for 10 minutes using test tubes that do not contain separation gel are optimal in terms of the number of platelets. Plasma intake from the lower layer of the obtained sample after centrifugation is always accompanied by the inclusion of leukocytes in its composition, which can lead to undesirable tissue reactions when it is used.
Conclusion: To obtain PRP, it is possible to use standard laboratory equipment in the centrifugation mode from 415 to 1660 g for 10 minutes using test tubes that do not contain separation gel. Plasma sampling for clinical use should be carried out from the middle layer of the obtained sample.
About the Authors
S. B. BazlovRussian Federation
Sergey B. Bazlov, Cand. Sci. (Med.), Associate Professor, Department of Faculty and Hospital Surgery
4, M. Sedina str., Krasnodar, 350063
K. I. Melkonian
Russian Federation
Karina I. Melkonian, Cand. Sci. (Med.), Associate Professor, Head of the Central Research Laboratory
Krasnodar
T. V. Rusinova
Russian Federation
Tatiana V. Rusinova, Cand. Sci. (Bio.), Research Fellow, Central Research Laboratory
Krasnodar
K. I. Popandopulo
Russian Federation
Konstantin I. Popandopulo, Dr. Sci. (Med.), Head of the Department of Faculty and Hospital Surgery
Krasnodar
N. V. Marchenko
Russian Federation
Nikolay V. Marchenko, Cand. Sci. (Med.), Associate Professor, Department of Faculty and Hospital Surgery
Krasnodar
D. D. Shevchuk
Russian Federation
Daniil D. Shevchuk, 5th year student, Medical Faculty
Krasnodar
References
1. Sánchez M, Andia I, Anitua E, et al. Platelet rich plasma (PRP) biotechnology: concepts and therapeutic applications in orthopedics and sports medicine. Innovations in Biotechnology. 2012:113–138. https://doi.org/10.5772/28908
2. Marx RE, Carlson ER, Eichstaedt R. Platelet rich plasma: growth factor enhancement for bone grafts. Oral Surg. 1998;85(6):638–646. https://doi.org/10.1016/s1079-2104(98)90029-4
3. Boldyreva OV, Vakhrushev SG, Toropova LA. The use of plasma enriched with platelets in medical practice. Modern problems of science and education. 2016;5. (In Russ.).
4. Airapetov GA. The possibilities of using platelet-rich plasma in diseases and injuries of large joints. Medical council. 2019;1:84–87. (In Russ.). https://doi.org/10.21518/2079-701X-2019-1-84-87
5. Medvedev VL, Opolskiy AM, Kogan MI. Prospects for the development of regenerative technologies. Current knowledge of platelet rich plasma and the possibility of its application in treatment of complicated urological diseases. Kuban Scientific Medical Bulletin. 2018;25(3):155–161. (In Russ.). https://doi.org/10.25207/1608-6228-2018-25-3-155-161
6. Arsyutov DG. Surgery of rhegmatogenous retinal detachment with the use of platelet-rich plasma (PRP). Practical medicine. 2018;3(114):11–13. (In Russ.).
7. Fasakhov RR, Gaizatullin RR. Combined therapy contractures of the hand joints. Norwegian Journal of development of the International Science. 2020;51:50–53. (In Russ.). https://doi.org/10.24412/3453-9875-2020-51-2-50-52
8. Korovin AYa, Bazlov SB, Andreeva MB, et al. Treatment of necrotizing infection in patients with chronic arterial insufficiency of the lower extremities. Pirogov Journal of Surgery. 2019;10:43–49. (In Russ.). https://doi.org/10.17116/hirurgia201910143
9. Kim DH, Je YJ, Kim CD, et al. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol. 2011;23(4):424–431. https://doi.org/10.5021/ad.2011.23.4.424
10. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin appendage disorders. 2018;4(1):18–24. https://doi.org/10.1159/000477353
11. Shen L, Yuan T, Chen S, et al. The temporal effect of platelet–rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta–analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16. https://doi.org/10.1186/s13018-017-0521-3
12. Conde-Montero E, de la Cueva Dobao P, Martínez González J. Platelet-rich plasma for the treatment of chronic wounds: evidence to date. J Chronic Wound Care Management and Research. 2017;4:107–120. https://doi.org/10.2147/cwcmr.s118655
13. Ehrenfest D, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends in Biotechnology. 2009;27(3):158–167. http://doi.org/10.1016/j.tibtech.2008.11.009
14. Degen RM, Bernard JA, Oliver KS, et al. Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition. HSS J. 2017;13:75–80. https://doi.org/10.1007/s11420-016-9519-3
15. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost., 2004;91:4–15. PMID:1469156. https://doi.org/10.1160/TH03-07-0440
16. Sulaeva ON. Obtaining of platelet-rich plasma: myths and reality. World of Medicine and Biology. 2017;3(61):150–153. (In Russ.). https://doi.org/10.26724/2079-8334-2017-3-61-150-153
17. Piao L, Park H, Jo CH. Theoretical prediction and validation of cell recovery rates in preparing platelet-rich plasma through a centrifugation. PloS One. 2017;12(11):e0187509. https://doi.org/10.1371/journal.pone.0187509
18. Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. PMID: 33096812. https://doi.org/10.3390/ijms21207794
19. Sister D. PRP: the new frontier in regenerative medicine and aesthetic medicine. Firence; 2016:58.
20. Drago L, Bortolin M, Vassena C, et al. Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS One. 2014;9:e107813. https://doi.org/10.1371/journal.pone.0107813
21. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–496. PMID: 15085519. https://doi.org/10.1016/j.joms.2003.12.003
Review
For citations:
Bazlov S.B., Melkonian K.I., Rusinova T.V., Popandopulo K.I., Marchenko N.V., Shevchuk D.D. On the issue of obtaining platelet-rich plasma. Innovative Medicine of Kuban. 2022;(1):38-43. (In Russ.) https://doi.org/10.35401/2500-0268-2022-25-1-38-43